ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEPHEN FANNING DO

Internal Medicine

3,390

$176K

229
193 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

LEWIS WEINER MD

Internal Medicine

3,154

$176K

121
112 are 65+

N/A

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

PRIYA BANSAL M.D.

Internal Medicine

4,478

$174K

248
206 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $51

TESFAYE MEREN MD

Internal Medicine

3,757

$157K

185
158 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

ALBERTO SAVORETTI M.D.

Internal Medicine

2,789

$156K

191
162 are 65+

N/A

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

ABENA ADDO M.D.

Internal Medicine

2,936

$147K

141
84 are 65+

N/A
N/A

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

JENNIFER JEREMIAH MD

Internal Medicine

3,244

$140K

182
164 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $51

CHRISTOPHER BROWN MD

Internal Medicine

2,127

$122K

176
150 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

MARCEL BAVOUX D.O.

Internal Medicine

3,192

$111K

477
246 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$35
Average prescription price

Avg: $51

MICHELLE ANVAR MD

Internal Medicine

2,697

$103K

210
158 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

KELLY MCGARRY MD

Internal Medicine

2,418

$99.2K

117
84 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $51

CARLA MARTIN MD

Internal Medicine

1,395

$94K

88
52 are 65+

N/A
N/A

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $51

LISA NOYES-DUGUAY M.D.

Internal Medicine

845

$75.3K

80
63 are 65+

N/A

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $51

MARISA VANPOZNAK MD

Internal Medicine

1,217

$61K

80
50 are 65+

N/A
N/A

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

CAROLINA FONSECA VALENCIA M.D.

Internal Medicine

1,128

$40.4K

61
45 are 65+

N/A
N/A

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

HAO HUANG M.D.

Internal Medicine

77,745

$4.15M

1350
1175 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

RICHARD RUGGIERI M.D.

Internal Medicine

34,402

$1.78M

1113
901 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

AVANISH MEHTA M.D.

Internal Medicine

27,797

$1.56M

452
387 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

RALPH SANTORO M.D.

Internal Medicine

29,193

$1.51M

693
610 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

ANTHONY LOMBARDI MD

Internal Medicine

27,497

$1.5M

768
637 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

AHMAD AL-RAQQAD M.D.

Internal Medicine

22,682

$1.11M

551
484 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

GREGORY ALLEN D.O.

Internal Medicine

18,922

$1.05M

484
330 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

AMY GOLDFARB MD

Internal Medicine

6,844

$1.04M

236
163 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$151
Average prescription price

Avg: $51

JEFFREY DROGIN MD

Internal Medicine

13,818

$1M

651
614 are 65+

N/A
N/A

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $51

NICHOLAS TURILLI D.O.

Internal Medicine

16,104

$905K

631
572 are 65+

N/A

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank